In occlusion/occlusion-like syndromes affecting both periphery and brain (portal hypertension, caval hypertension, intracranial hypertension), BPC-157 simultaneously normalized blood pressure disturbances, healed gastrointestinal and liver lesions, minimized brain lesions and hemorrhage, prevented thrombosis, and preserved neurological function
The cardiovascular and respiratory side effects include chest pain, tachycardia (increased heart rate), heart palpitations, low blood pressure, and chest tightness, cough with or without production of pink frothy sputum, wheezing and difficulty breathing
Peptides that accelerate healing, reduce inflammation, and support tissue regeneration for athletes and recovery
Week 3-4: Recovery from training improves
In the United States, penta deca peptide arginate is available through licensed healthcare providers and compounding pharmacies, unlike BPC-157 acetate which the FDA classified as a Category 2 substance